# Sensible Biotechnologies, Inc. — Form D

Sensible Biotechnologies, Inc. of Claymont, DE, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-21. The offering totals $3.0M, of which $1.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-02-21
- Form: D
- Accession: 0001964363-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.8M
- Remaining: $1.2M
- Investors: 18
- Date of first sale: 2023-02-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473903

## Issuer

- Name: Sensible Biotechnologies, Inc.
- CIK: 0001964363
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2093 Philadelphia Pike #3008, Claymont, DE, 19703
- Phone: 44 7599 496 330

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Miroslav Gasparek | Director | Claymont, DE |
| Marian Kupculak | Director | Claymont, DE |
| Miroslav Gasparek | Executive Officer | Claymont, DE |
| Marian Kupculak | Executive Officer | Claymont, DE |

## More

- [CIK 1964363 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1964363&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001964363-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.